(
a) To examine whether Rho1 inhibition influences ectodermal shortening, we measured the ectoderm cross-section area as a proxy of the ectodermal cell length (ectoderm thickness) for Late Group embryos. T0 is the onset of apical constriction. Each color is one Late Group embryo. In three out of five Late Group embryos, Opto-Rho1DN stimulation resulted in a slight increase in ectoderm thickness (magenta boxes). This increase is both mild and transient, and the trend of change in thickness rapidly resumed the pre-stimulation pattern (in 2–3 min). In the remaining two out of five Late Group embryos, Opto-Rho1DN stimulation did not have an obvious impact on ectoderm thickness (blue boxes). (
b) Relative change of ectoderm cross-section area in non-stimulated control embryos and Late Group embryos. Shown is percent ectoderm area change within a 1.7-min duration, either immediately after stimulation (Late Group embryos) or after the maximal ectoderm area was reached (non-stimulated control embryos). Each data point represents one embryo. Wilcoxon rank-sum test is used for statistical comparison. The observed impact of Opto-Rho1DN stimulation on ectoderm thickness change was both mild and transient even though Rho1 inhibition was persistent, suggesting that Rho1 inhibition did not directly impact ectodermal shortening. Instead, the observed effect is likely to be an indirect consequence of the mild tissue relaxation near the constriction domain upon Rho1 inhibition (cell 9 in
Figure 5f – j;
Figure 6—figure supplement 1; data not shown).